In:
BIOspektrum, Springer Science and Business Media LLC, Vol. 27, No. 6 ( 2021-10), p. 632-633
Abstract:
The production of peptides as active pharmaceutical ingredients (APIs) by recombinant technologies is of emerging interest. A reliable production platform, however, is still missing due to inherent peptide characteristics such as proteolytic sensitivity, aggregation, and cytotoxicity. We developed a new approach — Numaswitch™. It solves present limitations and provides a cost-efficient production platform for diverse peptides and hard-to-be-expressed proteins.
Type of Medium:
Online Resource
ISSN:
0947-0867
,
1868-6249
DOI:
10.1007/s12268-021-1650-0
Language:
German
Publisher:
Springer Science and Business Media LLC
Publication Date:
2021
detail.hit.zdb_id:
1236314-5
detail.hit.zdb_id:
2203536-9
SSG:
12
SSG:
15,3
Bookmarklink